Hand hygiene using a new hand-cleansing formulation without sanitizers: Effect on Staphylococcus aureus removal and recovery of properties against skin damage  by Asaoka, Kentaro et al.
Major Article
Hand hygiene using a new hand-cleansing formulation without
sanitizers: Effect on Staphylococcus aureus removal and recovery of
properties against skin damage
Kentaro Asaoka RC a,b, Shiro Endo MD, PhD a,*, Yuki Suzuki RN a, Satoru Komuro RN c,
Tadanobu Nemoto MD, PhD d, Mitsuo Kaku MD, PhD a
a Department of Infection Control and Laboratory Diagnostics, Internal Medicine, Tohoku University Graduate School of Medicine, Sendai City, Miyagi,
Japan
b Department of Research and Development, Household Laboratory, Kao Corporation, Wakayama City, Wakayama, Japan
c Geriatric Health Services Facility “Cosmos”, Sendai City, Miyagi, Japan
d Izumi Orthopedic Hospital, Sendai City, Miyagi, Japan
Key Words:
Bioﬁlm
Potassium oleate
The surface evaluation of scaliness
Background: Staphylococcus aureus is known to form a bioﬁlm and colonize on damaged skin of the hands.
We investigated changes in the quantity of S aureus on the hands and changes in skin damage when using
a hand-cleansing formulation with potassium oleate but without a sanitizer (formulation A), which is
highly effective in removing S aureus bioﬁlm and causes minimal skin damage.
Material and Methods: The participants (14 medical staff members) used 2 types of hand-cleansing for-
mulations (formulations A and B), each for 4 weeks. S aureus of the hands was cultured from swab samples
on agar plates. Surface of hands was measured using an ultraviolet light microscope.
Results and Discussion: The quantity of S aureus after using formulation A for 4 weeks was 101.08 ± 0.05
CFU/mL, a statistically signiﬁcant decrease from the quantity of S aureus (101.59 ± 0.19 CFU/mL) just before
use (P = .029). Also, dryness of hand surfaces decreased. With formulation B, the quantity of S aureus did
not signiﬁcantly change from before to after use (P > .05). This presumably occurs because formulation
A gently removes S aureus bioﬁlm.
Conclusions: Formulation A removed S aureus from the hands of participants, and skin damage on the
hands improved.
© 2016 Published by Elsevier Inc. on behalf of Association for Professionals in Infection Control and
Epidemiology, Inc. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).
Health care-associated infections prolong patient hospitaliza-
tion, increase health care costs, and increase mortality rates.1 The
incidence of Staphylococcus aureus infections, a leading cause of
health care-associated infections, is particularly high, and preven-
tion is important because of a high rate of antibiotic resistance.1 In
general, microorganisms are likely to be transmitted bymedical staff
to patients by hand contact.2 This means that hand hygiene is im-
portant in preventing infections. Various measures, including
increased compliance with hand hygiene protocol using alcohol-
based handrub solutions, has been somewhat effective.3 However,
despite the use of hand hygiene protocol, outbreaks of S aureus in-
fection on damaged hand skin have been reported,4-6 and disinfection
and removal of S aureus on damaged hand skin has reportedly been
diﬃcult.7
Therefore, disinfection and removal of colonized S aureus from
damaged skin is a challenge, and this colonized S aureus can be a
major problem in medical settings. More effective hand hygiene is
necessary to remove colonized S aureus, but because skin damage
can persist as a result of alcohol-based hand hygiene, further S aureus
colonization is likely, thus creating a repetitive cycle.8-11 Damaged
skin is also a hindrance to hand hygiene, and if required hand hygiene
measures are not implemented, the risk of S aureus and other bac-
terial infections via hand contact increases.12
In a previous study, we conﬁrmed the possibility of the pres-
ence of a S aureus bioﬁlm on the surface of the hands of medical
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personnel. Therefore, as a factor associated with colonization of S
aureus on damaged skin of the hands, we turned our attention
toward this S aureus bioﬁlm. In other words, we hypothesized that
if S aureus bioﬁlm can be removed while causing minimal hand skin
damage, S aureus can effectively be removed and hand skin damage
itself can be improved. In the current study, we enrolled medical
staff members and investigated changes in the quantity of S aureus
on their hands and changes in skin damage when using a hand-
cleansing formulation (formulation A) that is highly effective in
removing S aureus bioﬁlm, yet caused minimal damage to the skin
of the hands.
MATERIALS AND METHODS
Hand-cleansing formulations used in this study
• Formulation A: Foam-type formulation containing potassium
oleate as the chief component, and potassium acyl glycinate and
1,3-butylene glycol, but without a sanitizer. (This product is to
be launched by Kao Corporation, Tokyo, Japan).
• Formulation B: Foam-type formulation containing potassium
laurate as the chief component, and isopropyl methyl phenol
as a sanitizer (commercially available).
Cell viability
Cell viability13 was calculated using a 3-dimensional skin model
of reconstructed human epidermis (LabCyte EPI-MODEL, Japan Tissue
Engineering Co Ltd, Aichi, Japan) to predict skin damage from the
hand-cleansing formulations. Other than a formulation exposure time
of 10minutes to the LabCyte EPI-MODEL, the procedure andmethod
for calculating cell viability were performed according to the ma-
nufacturer’s instruction.
S aureus bioﬁlm removal rate
For the bioﬁlm formation, Tryptic Soy Broth No. 2 (Sigma-
Aldrich Co LLC, St Louis, MO) was used for preculture, then 0.15 mL
S aureus (NBRC13276) solution from the same medium, diluted to
an optical density at 600 nm of 0.1, was added to the wells of 96-
well plates.14,15 These were cultured at 37°C for 48 hours. To measure
bioﬁlm removal, 0.2 mL of each hand-cleansing formulation was
placed in contact with the formed bioﬁlm at room temperature for
1 minute. The quantity of residual bioﬁlm was measured by stain-
ing with 0.1% crystal violet solution, decolorizing with ethanol, and
measuring absorbance at 570 nm. The S aureus bioﬁlm removal rate
was calculated as shown below. Tryptic Soy Broth No. 2 without S
aureus was used as a blank. Saline was used as a control.
Bioﬁlm removal rate
The rate of bioﬁlm removal was determined by the equation
(%) = (C − test) / (C − B) × 100, where B = absorbance of blank, C = ab-
sorbance of control, and Test = absorbance after using test hand-
cleansing formulations.
Hand-cleansing formulation: Commissioned test
Participants
A survey was conducted among 63medical staff members at Ger-
iatric Health Services Facility “Cosmos” on July 14, 2014. S aureus
was isolated from swab samples of the hands in 8 participants, and
6 participants responded that they were concerned about hand
roughness (skin damage) during the winter. Testing was per-
formed in these 14 participants. The participants were divided into
2 groups (A and B) for testing, based on which ﬂoor they staffed.
All participants met the following conditions during the test period:
no current use of drugs such as steroids during the study period,
not pregnant or nursing, and no change in brand or frequency of
use of any hand products during this time.
Setting and design
Figure 1 shows the test schedule. The test was conducted between
November 4, 2014, andMarch 9, 2015. This was a prospective, cross-
over, double-blind commissioned test. Formulations A and B were
each used for 4 weeks. To ensure that the hand conditions of the
participants were the same before use of formulations A and B, a
2-week controlling period was established. To eliminate any car-
ryover effect between formulations A and B, the time required for
stratum corneum turnover was considered, and a 6-week washout
period was established. During the controlling and washout periods,
formulation C, which is regularly used at Geriatric Health Services
Facility “Cosmos”, was used. Formulation C is a liquid-type com-
mercially available product containing potassium laurate as its chief
component and isopropyl methyl phenol. At −2, 0, 2, and 4 weeks
of using formulations A and B, hand roughness (ie, skin damage)
and the quantity of S aureus and aerobic bacteria from swab samples
were assessed. Testing was performed 20 minutes after the par-
ticipants had washed their hands using the speciﬁed formulation
and hands had been placed at rest. This study was approved by an
institutional review board of Geriatric Health Services Facility
“Cosmos,” and the procedure of this study conformed to the prin-
ciples of the Declaration of Helsinki.
Fig 1. Test schedule for evaluation of hand-cleansing formulations. Solid arrows denote the duration of use and dashed arrows denote the controlling and washout periods.
Formulations indicated under each arrow were used during that period.
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Quantity of S aureus from swab samples
Bacterial samples from the hands were obtained by swabbing
the skin. Cultures were performed using mannitol salt agar with egg
yolk (Kanto Chemical Co Inc, Tokyo, Japan).
Hand roughness (ie, skin damage) assessment
Images of the dorsum the hand were obtained with a Visioscan
VC 98 high-resolution ultraviolet light microscope and were ana-
lyzed using SELS-2000 software (Courage +Khazaka electronic GmbH,
Cologne, Germany). The surface evaluation of scaliness (SEsc) value,
an indicator of scaliness and dryness of keratin, was calculated as
the mean of 4 values after excluding the maximum and minimum
values from 6 sites (3 each of the right and left hands).
Data analysis
The data were statistically analyzed using the Mann-Whitney U
test and Excel Statistics 2012 software (Social Survey Research In-
formation Co Ltd, Tokyo, Japan). The error bars in all ﬁgures represent
standard error. A P value of <.05 was considered statistical signiﬁcant.
RESULTS
Cell viability and S aureus bioﬁlm removal effects using formulations
A and B
Cell viabilities using formulations A and B were 97% and 2%, re-
spectively, and the S aureus bioﬁlm removal rates for formulations
A and B were 84% and 63%, respectively.
Changes in quantity of S aureus
Figure 2 shows the results. After using formulation A for 2 weeks,
the quantity of S aureuswas signiﬁcantly decreased to 101.10 ± 0.10 CFU/
mL, and compared with the values at −2 weeks and 0 weeks
(101.55 ± 0.21 CFU/mL [P = .046] and 101.59 ± 0.19 CFU/mL [P = .022], re-
spectively). In addition, after using formulation A for 4 weeks, the
quantity of S aureus was 101.08 ± 0.05 CFU/mL, a signiﬁcant decrease
compared with 0 weeks (P = .029). However, after using formula-
tion B, the quantity of S aureus did not signiﬁcantly change compared
with before use (P > .05). 95% conﬁdence intervals of formulation
A and B at −2 weeks were 101.13 ~ 101.97 and 100.97 ~ 101.31, respec-
tively (P = .12). Also, those of formulation A and B at 0 week were
101.23 ~ 101.95 and 101.00 ~ 101.32, respectively (P = .09).
Changes in SEsc values
Figure 3 shows the differences in SEsc values between partici-
pants’ hands before and after the handwashing protocol. After using
formulation A for 2 and 4 weeks, the SEsc values of 2.02 ± 0.59 and
2.02 ± 0.38, respectively, were less than the SEsc values at −2 and
0 weeks of 2.85 ± 0.48 and 2.60 ± 0.37, respectively. In particular, the
SEsc values at 2 weeks after use were signiﬁcantly decreased com-
pared with −2 weeks (P = .042). However, there were no statistically
signiﬁcant changes in SEsc values before and after using formula-
tion B (P > .05).
Figure 4 shows the participant with the most pronounced ef-
fectiveness. After using formulation A for 4 weeks, the white areas
of scaliness and dryness decreased, together with a reduction in the
SEsc value.
DISCUSSION
Measurement of cell viability in 3-dimensional skin models has
been used in animals as an alternative method for evaluating drug-
related primary skin irritation and skin erosion tests.13 Our cell
viability testing suggested that formulation A causes minimal hand
skin damage, similar to that caused by saline. The use of potas-
sium oleate in formulation A probably accounts for the high (84%)
Fig 2. Changes in quantity of Staphylococcus aureus on hands during use of hand-
cleansing formulations. Line with circles indicates formulation A, line with triangles
indicates formulation B. CFU, colony-forming units. *P < .05.
Fig 3. Changes in Surface Evaluation of scaliness (SEsc) values on dorsal hands during
use of hand-cleansing formulations. Lines with circles, Formulation A; line with tri-
angles, Formulation B; *P < .05.
Fig 4. Change in appearance and Surface Evaluation of scaliness (SEsc) of partici-
pant #09’s dorsal hand before and after using Formulation A.
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bioﬁlm removal rate with minimal hand skin damage. The mech-
anism, which is currently being investigated, probably involves the
molecular size of potassium oleate. As shown in Figure 2, formu-
lation A caused changes in the quantity of S aureus had decreased.
We checked that there were no statistically signiﬁcant changes in
the quantity of aerobic bacteria from before to after using formu-
lation A (P > .05, data not shown). This suggests that formulation
A removes S aureus without affecting the resident microbial ﬂora
of the hands. Further detailed investigation is planned using
metagenomic analysis of changes in the microbial ﬂora before and
after using formulation A and B. The decrease in the quantity of S
aureus is not due to disinfection, but rather to the removal of S aureus
bioﬁlm. We concluded this because formulation A contains no sani-
tizer (disinfectant) and because the presence of S aureus bioﬁlmwas
detected on the hands of 4 participants at the beginning of the study,
on July 22, 2014. All 4 had a decrease in the quantity of S aureus
after using formulation A.
As shown in Figures 3 and 4, formulation A decreased the SEsc
values compared with before use, scaling and dryness decreased,
and hand skin damage was improved. This was due to the quanti-
ty of S aureus on the skin and produced toxins were decreased and
formulation A causesminimal hand skin damage, so there is minimal
hand skin damage, even with frequent washing. Our survey on July
14, 2014, showed a positive correlation between SEsc value and S
aureus quantity. In other words, improvement in scaling and dryness
may be linked to a decrease in S aureus quantity, and the results
of Figures 2 and 3 indeed support this hypothesis.
After using formulation B, although there were no changes in
the quantities of S aureus, aerobic bacteria (data not shown), and
in the SEsc values compared with before use (P > .05). Based on the
survey during the conduction of this test, the frequency of hand-
washing and use of hand care products did not change from before
to during the period of use of formulation A. Moreover, a compar-
ison between formulations A and B showed no differences in baseline
frequency of handwashing or use of hand care products.
CONCLUSIONS
The use of hand-cleansing formulation with potassium oleate
but without a sanitizer (formulation A) by medical staff members
improved hand skin damage, and this is promising as a means of
improving compliance with hand hygiene measures. Formulation
A also effectively removed S aureus from the hands. Therefore, for-
mulation A can reduce the risk of health care-associated, medical
staff hand contact-caused S aureus infections.
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